Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Disease

3 Biotech Stocks to Buy Before December and 1 to Sell

The biotech industry is increasingly gaining prominence due to the growing prevalence of chronic disease and advancements in drug discovery and development. Given the industry’s solid growth prospects, it could be wise to buy quality biotech stocks, Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and United Therapeutics (UTHR). However, we think…

StockNews.com

What is the difference between Alzheimer’s and dementia?

New drug proven to slow onset of degenerative brain disease as scientists hail ‘breakthrough’

The Independent UK

Exciting new drug is ‘beginning of the end’ for Alzheimer’s – so what is it and when could it be available?

As trial results bring hope of an effective treatment, Lisa Salmon asks The Alzheimer’s Society what it means for people right now.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Data shows drug slowing Alzheimer’s but doubts over effect remain

Lecanemab modestly slows disease’s inevitable worsening, but it remains unclear how much of a difference it will make.

Al Jazeera

Home Office ignored warnings on diphtheria weeks before Manston outbreak

Exclusive: Call for public inquiry after authority warned of ‘severe outcomes’ in processing centres and called for vaccinations

The Independent UK

Scotland's chief vet warns bird flu cases could rise in coming weeks

CASES of avian flu in Scotland could increase in the coming weeks, an expert has warned.

The National (Scotland)

Racing to develop Africa’s next-gen vaccines before new pandemic

How scientists across Africa plan to use mRNA technology to fight diseases and tackle inequities in global health.

Al Jazeera

Read news from The Economist, FT, and more,
with one subscription

Raw honey could help reduce blood sugar and cholesterol levels, study finds

Replacing sugar with honey offers health benefits and could help prevent heart and metabolic diseases, according to a recent study

Evening Standard

New Alzeimher’s drug could offer major breakthrough in treating disease

Scientists are optimistic about Lecanemab, which has slowed down cognitive decline in clinical trials

Dublin Live

Dog not eating? Here’s 11 things you need to check, according to a vet

Everything you need to know if your dog is not eating.

PetsRadar

New Alzheimer's drug could be 'beginning of the end' for disease

It's been hailed as a momentous breakthrough after decades of failure in the search for effective treatment

Nottingham Post

Drug proven to slow decline in Alzheimer patients

Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients

Manchester Evening News

Farts say more about your health than you think — now, scientists are listening

Scientists are developing an AI algorithm to detect diseases from the sounds of bathroom activities, which could tame future epidemics.

Inverse

‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

The New Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Reuters

Excitement, defiance for young Chinese in COVID 'tipping point' protests

When Yang, a Shanghai office worker, saw video clips of a burning building in western China, a disaster in which 10 people were killed, she said she could not contain her anger over tough COVID-19 measures three years into the pandemic.

The Independent UK

Five early signs of pancreatic cancer as man battles disease for a second time

After having pancreatic cancer twice, Charles Czajkowski is dedicating the rest of his life to raising awareness of the early symptoms

Daily Record

New Alzheimer's drug hailed as 'game-changing' as it's proven to slow disease

The drug slowed the disease progression by 27 percent compared to patients taking the placebo.

WEKU

Study: Alzheimer's drug shows modest success slowing declines in memory, thinking

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

Evening Standard

Lecanemab: new Alzheimer’s drug hailed as ‘beginning of the end’ for disease

A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”.

Daily Mirror

Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease

Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease

Edinburgh Live

Young Scottish mum with rare kidney failure terrified her kids will be orphaned

Kerry Brown has issued an appeal for people to become live kidney donors after she has been left with just four per cent kidney function due to the extremely rare autoimmune disease called Goodpasture syndrome

Wales Online

Simple urine test could be used to diagnose early-stage Alzheimer’s disease

The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment

The Independent UK

14 symptoms of pancreatic cancer you’re most likely to ignore

A pancreatic Cancer UK specialist nurse outlines easy-to-ignore signs of the disease

The Independent UK

Molecule in urine ‘could be the first to reveal early-stage Alzheimer’s disease’

The findings suggest a simple urine test could be used to identify people who are in the early stages of the disease.

1 … 500 501 502 503

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Alzheimer Research UK

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.